Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,282,585
-
Share change
-
+11,249,541
-
Total reported value
-
$944,102,478
-
Put/Call ratio
-
29%
-
Price per share
-
$30.18
-
Number of holders
-
119
-
Value change
-
+$539,158,911
-
Number of buys
-
105
-
Number of sells
-
34
Institutional Holders of CELATOR PHARMACEUTICALS INC - COM (CPXX) as of Q2 2016
As of 30 Jun 2016,
CELATOR PHARMACEUTICALS INC - COM (CPXX) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,282,585 shares.
The largest 10 holders included
CAXTON CORP, ALPINE ASSOCIATES MANAGEMENT INC., Magnetar Financial LLC, VANGUARD GROUP INC, venBio Select Advisor LLC, CNH PARTNERS LLC, FMR LLC, DEUTSCHE BANK AG\, GLAZER CAPITAL, LLC, and GABELLI FUNDS LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.